Twist Bioscience (TWST) Gross Profit (2017 - 2026)

Twist Bioscience (TWST) has reported Gross Profit for 10 consecutive years, with $62.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Profit rose 21.75% year-over-year to $62.5 million in Q2 2026; TTM through Jun 2026 was $224.4 million, a 25.78% increase from a year earlier, with the FY2025 full-year figure at $191.0 million, up 43.23% from the prior year.
• Gross Profit was $62.5 million for Q2 2026 at Twist Bioscience, up from $57.1 million in the prior quarter.
• Over five years, Gross Profit peaked at $62.5 million in Q2 2026 and troughed at $18.4 million in Q1 2022.
• A 5-year average of $36.5 million and a median of $33.1 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit soared 78.48% in 2022 and fell 12.9% in 2023, its largest moves.
• Over 5 years, Gross Profit stood at $24.8 million in 2022, then increased by 16.78% to $29.0 million in 2023, then surged by 47.92% to $42.8 million in 2024, then grew by 25.99% to $54.0 million in 2025, then rose by 15.72% to $62.5 million in 2026.
• The last three Gross Profit figures came in at $62.5 million (Q2 2026), $57.1 million (Q1 2026), and $54.0 million (Q4 2025), per Business Quant data.